Collateral flow can prevent myocardial necrosis despite persistent coronary occlusion: insights using myocardial contrast echocardiography in patients  by Lepper, Wolfgang et al.
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>90% graded CS, respectively with p<0.01 by ANOVA). By contrast, hyperhemic MBV 
only decreased with the highest graded CS (10.3 + 1.3, 10.5:1: 1.9, 10.3 ± 1.6 and 8.9 + 
1.3% in <50%, 50-70%, 70-90%, and in >90% CS, respectively with p<0.05 ANOVA). As 
shown in the figure, calculated hyperhemic MBF correlated inversely with the severity of 
the underlying CS as previously described in animal experiments. Our study thus demon- 
strates that the physiological significance of human CS can be quantitatively evaluated 
by power modulation RT-MCE. 
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864-2 Reversible Perfusion Defects During Dipyridamole 
Myocardial Contrast Echocardiography for the 
Detection of Coronary Artery Disease: A Multicenter 
Study 
Roxv Senior, Wolfgang Lepper, Agnes Pasquet, George Chung, Rainer Hoffman, Jean- 
Louis Vanoverschelde, Sanjiv Kaul, Northwick Park Hospital, Harrow, United Kingdom, 
University of Virginia, Charlottesville, Virginia. 
Background: We hypothesized that stress myocardial contrast echocardiegraphy (MCE) 
technique can detect coronary artery disease (CAD) in the absence of prior infarction on 
the basis of reversible perfusion defects. 
Methods: 55 patients with suspected CAD and no previous myocardial infarction or wall 
motion abnormality were recruited from 3 centers in Europe. They underwent high 
mechanical index intermittent B-mode MCE during a continuous infusion of Sonazoid 
(Nycomed-Amersham) and coronary arteriography (CA) within 1 month of each other. 
Visual analysis of MCE data and quantitative CA were performed by blinded observers at 
2 different centers in the United States. 
Results: Forty-two (76%) had 2 50% stenosis of one or more coronary arteries. MCE 
detected reversible perfusion defect in one or more segment in 83% of these patients. 
The rate of CAD detection increased with higher degrees of stenosis: 88% in >75% 
stenosis and 100% in more than 90% stenosis. The specificity for a cut-off <50% steno- 
sis was 44% in this patient population with chest pain. The accuracy of dipyridamole 
MCE for the detection of >- 50% stanosis was 76%. 
Conclusion: MCE (using intermittent high mechanical index B-mode imaging) per- 
formed very well against quantitative coronary angiography for the detection of CAD in 
patients without previous infarction or wall motion abnormality. The relatively lower spec- 
ificity was probably related to selection bias in patients undergoing coronary angiography 
for chest pain evaluation. 
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864-3 Collateral Flow Can Prevent Myocardial Necrosis 
Despite Persistent Coronary Occlusion: Insights Using 
Myocardial Contrast Echocardiography in Patients 
Wolfoano Leooer. Eduardo Balcells, Jonathan R. Lindner, Sanjiv Kaul, Todd Belcik, Eric 
Powers, Kevin Wei, University of Virginia, Charlottesville, Virginia. 
Background: Primary determinants of infarct size include the duration of coronary occlu- 
sion, the size of the risk area, and also the adequacy of collateral perfusion. Myocardial 
blood flow (MBF) can now be quantified non-invasively with myocardial contrast echocar- 
diography (MCE). We hypothesized that the presence of adequate collateral MBF within 
the risk area can be determined with MCE, and would prevent significant no reflow injury 
despite a persistently occluded infarct-related artery (IRA). 
Methods: Patients presenting with a first acute ST-elevation myocardial infamtion at 
least 2 hours from symptom onset, and were found to have an occluded IRA were 
enrolled. The risk area was defined as the akinetic area on 2D echocardiogrephy. MCE 
was performed using continuous infusion of Optison (Mallinckrodt) and intermittent uitre- 
harmonic imaging (Agilent) prior to primary angioplasty (PCI). Collateral MBF velocity 
was quantified using the rate of rise of video intensity (VI) from pulsing interval versus VI 
curves. Infarct size was determined with MCE >48 hrs after PCI, and was defined as the 
area of no reflow (persistent hypoperfusion at a PI of >8 cardiac cycles) and expressed 
as a ratio of the risk area. 
Results: We enrolled 11 patients (7 male) who presented at a mean of 5.1+/-1,4 h from 
symptom onset. Median age was 58 yrs (range 36 - 83). The occluded IRA was identified 
as the left anterior descending in 4, right coronary in 6 and circumflex in 1. In 7 patients 
with no stanoses apart from the IRA, MBF velocity in normal myocardium was 0.73+/ 
10.25 s -1 . Coflaterel MBF velocity within the risk area ranged from 0 - 1.2 s "1 (mean 
0.49+/-0.47 s-l). A significant inverse correlation was found between collateral MBF 
velocity and the extent of no reflow (r=-0.79,p=0.001). Patients with no rstlow areas 
<50% of the risk area had significantly greater collateral MBF velocity than those with sig- 
nificant no reflow (0.93+/10.27 versus 0.12+/-0.14, p<0.001 ). 
JACC March 6, 2002 
Conclusion: Adequate collateral MBF velocity can prevent myocardial necrosis despite 
persistent occlusion of the IRA in patients. Quantification of collateral MBF velocity with 
MCE may be a useful non-invasive test in patients presenting with acute MI. 
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864-4 Incrementa l  Va lue o f  In t ravenous  Myocard ia l  Cont ras t  
Echocardiogrephy in the Pred ic t ion  o f  Contract i le  
Recovery and Left Ventricular Remodeling Ear ly  A f ter  
Acute Myocardial Infarction 
Giovanna Mengozzi, Roberta Rossini, Caterina Palegi, Giusappe Musumeci, Luigia 
Gardtano, Maria Moffese, Anna S. Petronio, Duccio Voltarrani, Vitantonio Di Bello, Mario 
Mariani, Cardio Thoracic Dpt University of Piss, Piss, Italy, Oncology Dpt University of 
Pisa, Pisa, Ital~ 
Background: Aim of this study was to assess the role of intravenous myocardial contrast 
echocardiography (IVMCE) in the prediction of contractile recovery and left ventricular 
(LV) remodeling in patients (Lots) with acute myocardial infarction (AMI), successfully 
treated with PTCA, 
Methods: Thirty-nine pts with AMI, successfully treated with PTCA, underwent IVMCE 
and low-dose dobutamine echocardiography (LDDE) on day 6 and 99mTc-Tstrofosmin 
SPECT at four weeks. IVMCE was graded serniquantitatively on a score of 0 (absent), 
0.6 (partial) and 1 (normal). Pts were considered to have microvascular impairment, if 
0.22 and an increase of LV end diastolic volume (EDV) >20%, respectively. 
Results: At six-month follow-up, 16 (41%) out of the 39 patients showed contractile 
recovery (Group I), while the remaining 23 (59%) pts did not (Group II). In the prediction 
of contractile recovery, IVMCE showed a very high sensitivity (94,7%) but a low specific- 
ity (43,5%); LDDE had a sensitivity of 94%, with a specificity of 70%; SPECT showed a 
sensitivity of 94% and a specificity of 39% (P=0,02). By stepwise multiple regression 
analysis, the reduction of WMSt during dobutarnine was the only significant independent 
predictor of contractile recovery (P=0.02). 
At six-month follow-up, 10 patients showed LV remodeling (group A), while 29 did not 
(group B). In the prediction of LV remodeling, IVMCE had a very high sensitivity (100%) 
and specificity (96%). LDDE showed a high sensitivity (80%) and a lower specificity 
(69%), while SPECT showed a sensitivity of 70% and a specificity of 86% (P=0.007). 
At stepwise multiple regression analysis, microvascular integrity at IVMCE was the only 
significant independent predictor of LV remodeling (P<0.0001; O.R. 0.34), In the predic- 
tion of LV remodeling, IVMCE increased the chi-square from 40.1 (obtained using clini- 
cal, basal echocardiographic, LDDE and SPECT data) to 88.2, while in the prediction of 
contractile recovery, no increase in chi-square was obtained. 
Conclusions: IVMCE seems to be an important diagnostic tool, able to predict contractile 
recovery and LV remodeling after AMI. In the prediction of LV remodeling, it can add 
incremental value to LDDE and SPECT. 
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864-5 M ic roc i rcu la t ion  Recovery  Af ter  Primary Coronary 
Angioplaaty in Pat ients  With Acute Myocardial 
infarction Treated With Abe ix imab or  In t racoronary  
Adenosina 
Anna S, Petronio, Giuseppe Musumeci, Carmela Nardi, Ugo Limbruno, Giovanni 
Amoroso, Roberto Bagiini, Caterina Palegi, Mario Mariani, CardioThoracic Dpt University 
of Pisa, Piss, Italy. 
Background: Despite the recanalization of the infarct related artery (IRA), microvascular 
integrity of downstream myocardium affects the recovery of left ventricular (LV) function 
and patient outcome. We investigated the effects of Abciximab and Adenosine on 
microvascular integrity and LV functional recovery in patients (pts) with acute myocardial 
infarction (AMI) treated with primary coronary angioplasty (PTCA). 
Methods: Forty-seven pts (38 male; 57.1 ± 8 yrs), with first AMI (<6 hrs after onset), were 
treated successfully with primary PTCA. Before the procedure pts were randomized to 
abciximab (0.25 mcg/kg bolus plus 12-h infusion; Group A, n = 17), intracoronary adeno- 
sina (4 mg in 2 mL saline; Group B, n = 15 ) and conventional therapy (Group C, n = 15). 
Baseline clinical and angiographic characteristics were similar. Myocardial Contrast 
Echocardiography (MCE), using intracoronary injection of sonicated contrast medium, 
was performed immediately after successful PTCA; at 48 hrs and at 1 month MCE was 
performed using intravenous injection of echocontrest medium. Myocardial perfusion 
with MCE was scored as 0 (absent), 0.5 (partial) or 1 (normal). For each patient a pertu- 
sion score index (PSI) was calculated by averaging the contrast scores of the segments 
within the area at risk. Wall motion score index (WMSI) was assessed by 2D-echocardio- 
graphy on admission and 3 months later. 
Results: Immediately after IRA recanalization PSI was higher in abeiximab and adenos- 
ina treated pts than in those of Group C (Group A 0.83±0.13 vs. Group C 0.72±0.16; p 
<0.05. Group B 0.89±0.16 vs Group C; p<0.005); this result was confirmed at 48 hours 
(Group A 0.88±0.14 vs. Group C 0.75±0.17; p <0.05. Group B 0.9±0.15 vs Group C; 
p<0.05). At one month intravenous MCE, only abciximab pts still showed a higher PSI 
than Group C pts (0.88±0.18 vs. 0.63±0.3; p <0.005). At three months 2D-echo the mean 
improvement of WMSI from baseline to 90 clays was significantly higher in Group A pts 
(0.42±0.2 vs 0.14±0.1 vs 0.23±0.1; p<0.01 ). 
Conclusion: In pts with AMI treated by successful primary PTCA abciximab and adenos- 
ina may improves microvascular pertusion of the infarct related territory. Moreover aboix- 
imab improves LV functional recovery. 
